On February 8, 2019 Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage forms, reported that fourth quarter and full year 2018 financial results will be released on Wednesday, February 13, 2019 before the market opens (Press release, Cambrex, FEB 8, 2019, View Source [SID1234533191]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Company will host a conference call to discuss the financial results.

Fourth Quarter 2018 Earnings Conference Call
When: Wednesday, February 13, 2019 at 8:30 a.m. Eastern Time
Dial-in: 1-877-260-1479 for U.S.
1-334-323-0522 for International
Passcode: 2955208
Dial-in Replay: 1-888-203-1112 for U.S.
1-719-457-0820 for International
Passcode: 2955208
Available through Wednesday, February 20, 2019
Webcast: www.cambrex.com